Study of immune memory cells in kidney transplant patients
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at a type of immune cell (memory B cells) in patients who are waiting for a kidney transplant. It aims to understand how these cells react to HLA proteins, which may help improve transplant success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult waiting for a kidney transplant at CHU de Bordeaux
- You have antibodies against class I HLA (you are 'sensitized')
- You have had one of these sensitizing events: blood transfusion, pregnancy, previous transplant, or no known sensitizing event
- You have not received rituximab (a drug that affects certain immune cells)
- You are not currently taking immunosuppressive drugs
- You have no non-cutaneous cancer, chronic viral infection, acute infection, or recent vaccination within the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts in kidney transplant patients who may be experiencing rejection. It aims to better understand and improve treatment for transplant rejection.
This study tests whether a special immune-resetting treatment can help patients who have developed too many antibodies against donor kidneys get access to a compatible kidney transplant. The treatment uses chemotherapy and stem cell transplantation to 'reset' your immune system so it stops rejecting potential donor kidneys.
This trial tests if giving you back specially grown immune cells (called Tregs) made from your own blood can help your body accept a new kidney from a living donor with less rejection. It is for people who are ready for a first kidney transplant.
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
This study looks at certain immune cells (B cells) in the blood and kidney to better understand antibody-mediated rejection in kidney transplant patients. It might help doctors find new ways to diagnose or treat this type of rejection.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
Hear when a new Kidney Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.